Tara Lech/thrombosis.org
Feb 21, 2026, 12:41
Tara Lech: New Guidelines for Comprehensive, Evidence Based Management of PE
Tara Lech, Director of Anticoagulation Services at Beth Israel Lahey Health and Member Board of Directors at Anticoagulation Forum, shared a post LinkedIn:
“New guidelines for comprehensive, evidence based management of PE
Collaborated on and endorsed by 8 societies
What you will find:
- Acute PE Clinical Categories (A-E)
- Clearly defined risk factors to screen for during a targeted history and physical examination
- Overview of an effective PERT Team
- LMWH preferred over unfractionated Heparin for most patients
- Considerations for special populations (Obesity, Thrombotic APS, Brain Tumors, CKD, Pregnancy, Breastfeeding, Chronic Liver Disease)
- Recommendations for timing and utility of LMWH levels, noting Class III
Recommendation: No Benefit for most patients with acute PE ”
Stay updated with Hemostasis Today.
-
Feb 21, 2026, 12:42Iyas Daghlas: Contemporary Rates of Ischemic Stroke Following High-Risk TIA
-
Feb 21, 2026, 12:38Ney Carter Borges: Mechanistic Insights and Clinical Cardiovascular Outcomes of GLP-1 Receptor Agonists
-
Feb 21, 2026, 12:30Stephan Munich: How Has Stroke Care Evolved in The US?
-
Feb 21, 2026, 12:26Christian Dyzmann: A Case of An 84 Year Old Lady With Unknown Onset of Stroke
-
Feb 21, 2026, 12:23Lucy Rutten: An Important Mechanistic Insight Into Future Vaccine Safety
-
Feb 21, 2026, 12:17Bartosz Hudzik: Clarifying Pulmonary Embolism Care with the New AHA/ACC Guideline
-
Feb 21, 2026, 12:12Agata Grochowska: Thromboprophylaxis and Coagulation Challenges in Pancreatic Cancer
-
Feb 21, 2026, 12:08John Chuback: Recognizing the Early Warning Signs of DVT
-
Feb 21, 2026, 11:44Pedro Perez: This New PE Guideline Gives Practical Clues on Risk, Evaluation, and Care Pathways